RAPT Therapeutics Inc

NASDAQ:RAPT   9:48:16 AM EDT
20.40
+1.28 (+6.70%)
Earnings Announcements

RAPT Therapeutics Reports Third Quarter 2020 Financial Results

Published: 11/16/2020 13:43 GMT
RAPT Therapeutics, Inc. (RAPT) - Rapt Therapeutics Reports Third Quarter 2020 Financial Results.
Qtrly Loss per Share $0.60.
As of September 30, 2020, We Had Cash and Cash Equivalents and Marketable Securities of $122.8 Million.
Q3 Earnings per Share View $-0.58 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $1.28 Million
Adjusted EPS is expected to be -$0.58

Next Quarter Revenue Guidance is expected to be $0.74 Million
Next Quarter EPS Guidance is expected to be -$0.60

More details on our Analysts Page.